Mannose 6-phosphate (Man-6-P)-dependent trafficking is vital for normal development. The biogenesis of lysosomes, a major cellular site of protein, carbohydrate, and lipid catabolism, depends on the 300-kDa cation-independent Man-6-P receptor (CI-MPR) that transports newly synthesized acid hydrolases from the Golgi. The CI-MPR recognizes lysosomal enzymes bearing the Man-6-P modification, which arises by the addition of GlcNAc-1-phosphate to mannose residues and subsequent removal of GlcNAc by the uncovering enzyme (UCE). The CI-MPR also recognizes lysosomal enzymes that elude UCE maturation and instead display the Man-P-GlcNAc phosphodiester. This ability of the CI-MPR to target phosphodiester-containing enzymes ensures lysosomal delivery when UCE activity is deficient. The extracellular region of the CI-MPR is comprised of 15 repetitive domains and contains three distinct Man-6-P binding sites located in domains 3, 5, and 9, with only domain 5 exhibiting a marked preference for phosphodiester-containing lysosomal enzymes. To determine how the CI-MPR recognizes phosphodiesters, the structure of domain 5 was determined by NMR spectroscopy. Although domain 5 contains only three of the four disulfide bonds found in the other seven domains whose structures have been determined to date, it adopts the same fold consisting of a flattened β-barrel. Structure determination of domain 5 bound to N-acetylglucosaminyl 6-phosphomethylmannoside, along with mutagenesis studies, revealed the residues involved in diester recognition, including Y679. These results show the mechanism by which the CI-MPR recognizes Man-P-GlcNAc-containing ligands and provides new avenues to investigate the role of phosphodiester-containing lysosomal enzymes in the biogenesis of lysosomes.
Structural basis for recognition of phosphodiestercontaining lysosomal enzymes by the cationindependent mannose 6-phosphate receptor Mannose 6-phosphate (Man-6-P)-dependent trafficking is vital for normal development. The biogenesis of lysosomes, a major cellular site of protein, carbohydrate, and lipid catabolism, depends on the 300-kDa cation-independent Man-6-P receptor (CI-MPR) that transports newly synthesized acid hydrolases from the Golgi. The CI-MPR recognizes lysosomal enzymes bearing the Man-6-P modification, which arises by the addition of GlcNAc-1-phosphate to mannose residues and subsequent removal of GlcNAc by the uncovering enzyme (UCE). The CI-MPR also recognizes lysosomal enzymes that elude UCE maturation and instead display the Man-P-GlcNAc phosphodiester. This ability of the CI-MPR to target phosphodiester-containing enzymes ensures lysosomal delivery when UCE activity is deficient. The extracellular region of the CI-MPR is comprised of 15 repetitive domains and contains three distinct Man-6-P binding sites located in domains 3, 5, and 9, with only domain 5 exhibiting a marked preference for phosphodiester-containing lysosomal enzymes. To determine how the CI-MPR recognizes phosphodiesters, the structure of domain 5 was determined by NMR spectroscopy. Although domain 5 contains only three of the four disulfide bonds found in the other seven domains whose structures have been determined to date, it adopts the same fold consisting of a flattened β-barrel. Structure determination of domain 5 bound to N-acetylglucosaminyl 6-phosphomethylmannoside, along with mutagenesis studies, revealed the residues involved in diester recognition, including Y679. These results show the mechanism by which the CI-MPR recognizes Man-P-GlcNAc-containing ligands and provides new avenues to investigate the role of phosphodiester-containing lysosomal enzymes in the biogenesis of lysosomes.
carbohydrate recognition | lectin | lysosome biogenesis | protein targeting L ysosomes are acidified organelles that serve as the terminal degradative compartment of the phagocytic, autophagocytic, and endocytic pathways. The diverse degradative capacity of this organelle depends on a repertoire of over 60 different soluble acid hydrolases (e.g., proteases, glycosidases, nucleases, lipases, and phosphatases) and involves the continual delivery of these newly synthesized hydrolytic enzymes to the lysosome (reviewed in ref. 1). Two mannose 6-phosphate receptors (MPRs), the ∼300-kDa cation-independent MPR (CI-MPR) and the 46-kDa cation-dependent MPR (CD-MPR) ( Fig. 1 A and B) , carry out this process by binding to a unique posttranslational modification on their N glycans. In early Golgi compartments, UDP-N-acetylglucosamine: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GlcNAc-phosphotransferase; EC 2.7.8.17), differentiates lysosomal enzymes from other proteins in the secretory pathway by adding N-acetylglucosamine (GlcNAc)-1-phosphate to the C-6 hydroxyl group of mannose to form a phosphodiester, Man-P-GlcNAc (Fig. 1C) . A second enzyme, N-acetylglucosamine-1-phosphodiester α-N-acetylglucosaminidase (uncovering enzyme; EC 3.1.4.45), removes the GlcNAc moiety in the trans Golgi network (TGN) to generate a phosphomonoester, mannose 6-phosphate (Man-6-P) (Fig. 1C) . The resulting phosphorylated N glycans are heterogeneous in structure with respect to size, number of phosphorylated mannose residues, presence of Man-6-P and/or Man-P-GlcNAc, and the location of phosphomannosyl residues on the different branches of the N glycan, thereby providing a diverse array of potential ligands for the MPRs (2) (3) (4) (5) . Following the delivery of their cargo to endosomes, the receptors either return to the Golgi to retrieve additional acid hydrolases or move to the plasma membrane where the CI-MPR functions to internalize exogenous ligands (6, 7) . This phosphomannosyl recognition system is critical for normal development because a deficiency of GlcNAc-phosphotransferase activity, resulting in acid hydrolases lacking the phosphomannosyl tag, causes the lysosomal storage disorders mucolipidosis II and III (8) . Furthermore, a recent genetic study has made the intriguing observation that mutations in GlcNAc-phosphotransferase and the uncovering enzyme are associated with a common speech disorder, stuttering (9) . Studies using transgenic mice have shown that, unlike GlcNAcphosphotransferase-deficient mice (10), mice lacking the uncovering enzyme, which results in their acid hydrolases bearing phosphodiesters (Man-P-GlcNAc), grew normally and exhibit no detectable histologic abnormalities (11) . These studies also showed that secreted hydrolases from these animals bound to the CI-MPR but not the CD-MPR (11), a finding consistent with previous reports which demonstrated that the CI-MPR, but not the CD-MPR, binds phosphodiester-containing glycans (12, 13) . The CI-MPR's large extracellular region contains 15 homologous, contiguous domains that are referred to as "MRH" domains (Mannose 6-phosphate Receptor Homology domains) (14) due to their similar size (∼150 residues) and conservation of residues, including cysteines involved in disulfide bonding. The CI-MPR contains three carbohydrate binding sites located within MRH domains 3, 5, and 9 (reviewed in ref. 15) . In contrast, the CD-MPR's extracellular region contains only a single MRH domain (Fig. 1A and B) . Our recent analyses of truncated forms of the CI-MPR using a phosphorylated glycan microarray revealed that the three Man-6-P binding sites differ in their glycan specificity and identified domain 5 of the CI-MPR as the only known carbohydrate binding domain capable of recognizing Man-P-GlcNAc (16) (Fig. 1C) . Together, these results suggest that domain 5 of the CI-MPR is responsible for correctly targeting the phosphodiester-containing hydrolases in mice deficient in the uncovering enzyme, thereby allowing these animals to develop normally.
In this work, we describe the structural basis for the CI-MPR's ability to bind with high affinity to lysosomal enzymes bearing Man-P-GlcNAc. Solution structures of domain 5 of the CI-MPR in ligand-free and Man-P-GlcNAc-bound forms were solved by NMR and compared to the known crystal structures of domain 3 of the CI-MPR and the MRH domain of the CD-MPR, both of which are specific for the phosphomonoester Man-6-P. The solution structure shows that although domain 5 of the CI-MPR adopts the same fold as observed for the other known MPR MRH domains, the architecture of its binding pocket has been altered to accommodate a GlcNAc residue, and it utilizes a tyrosine and a tryptophan residue not found in the other phosphomonoester-specific MRH domains of the CI-MPR.
Results and Discussion
Man-P-GlcNAc-Containing Acid Hydrolases Are Internalized by Cells Expressing Mutant CI-MPR Lacking Functional Phosphomonoester Binding Sites. The crystal structure of 7 (i.e., domains 1-3, domains [11] [12] [13] [14] out of the 15 MRH domains of the CI-MPR and the single MRH domain of the CD-MPR have been determined to date, which shows that each of these MRH domains shares a similar fold (17) (18) (19) . Our previous crystal structures of the CD-MPR (17) and domains 1-3 of the CI-MPR (18) bound to Man-6-P identified conserved residues that serve as a signature motif for Man-6-P binding: CD-MPR (Q66, R111, E133, and Y143) and domain 3 of CI-MPR (Q348, R391, E416, and Y421) bind the 2-, 3-, and 4-hydroxyl groups of the mannose ring in the same manner. Structure-based sequence alignments of the CI-MPR's 15 MRH domains have shown that these four signature residues (Gln, Arg, Glu, and Tyr) are found in only three MRH domains (i.e., 3, 5, and 9) (Fig. 1B) . Furthermore, mutagenesis studies showed that each of these conserved residues is essential for carbohydrate binding by CD-MPR (20, 21) and domains 3, 5, and 9 of the CI-MPR (22, 23) .
To evaluate the role of domain 5 in lysosomal enzyme targeting, we took advantage of previously established stably transfected mouse L cell lines expressing either the wild-type CI-MPR or a double mutant, Dom3
Ala 9 Ala . The replacement of the essential arginine residue in domain 3 (Arg391) and domain 9 (Arg1290) (Fig. 1B) with alanine in the Dom3 Ala 9 Ala construct inactivates these phosphomonoester-specific binding sites (24) . Uptake studies were performed using the lysosomal enzyme, acid α-glucosidase (GAA), that was modified as described previously (23) to bear solely phosphomonoesters (GAA monoester) or phosphodiesters (GAA diester) on its N glycans. Stably transfected mouse L cells were incubated with 125 I-GAA monoester or 125 I-GAA diester, and the amount of specifically internalized radioactivity was determined in three independent experiments. As expected, cells expressing the wild-type CI-MPR internalized 125 I-GAA monoester and 125 I-GAA diester (Fig. S1 ). In contrast, cells expressing Dom3 Ala 9 Ala , which contains a single functional carbohydrate binding site (e.g., domain 5), were unable to internalize 125 I-GAA monoester, but internalized 125 I-GAA diester at 79%, 146%, and 41% the level of uptake observed by cells expressing the wild-type CI-MPR in trials 1, 2, and 3, respectively (Fig. S1) . The inability to detect significant levels of 125 I-GAA monoester internalized by these cells is likely due to our observation that a construct encoding domain 5 alone bound Man-PGlcNAc with a ∼14-to 18-fold higher affinity than Man-6-P (23) and no detectable binding to purified high mannose-type glycans containing Man-6-P phosphomonoesters (16) . Although these studies probe the receptor's ability to internalize extracellular ligands rather than providing a direct measure of its ability to traffic cargo from the TGN to endosomal compartments, taken together, the results indicate that domain 5 of the CI-MPR is responsible for delivering phosphodiester-containing lysosomal enzymes to the lysosome. Domain 5 Adopts the Conserved MRH Fold. Although mutagenesis studies of domain 5 demonstrated that the four conserved residues (Gln644, Arg687, Glu709, and Tyr714) predicted by a structure-based sequence alignment to be directly involved in binding the mannose ring are essential for Man-6-P binding (23) , this alignment (Fig. 1B ) also revealed that domain 5 lacks two cysteine residues that form a disulfide bridge in the binding pockets of the CD-MPR and domain 3 of the CI-MPR. To determine the structural basis for the CI-MPR's ability to recognize lysosomal enzymes containing phosphodiesters and to assess whether the lack of this disulfide bond impacts the overall structure and/or architecture of domain 5's binding pocket, the solution structures of domain 5 in ligand-free and ligand-bound states were determined using 3D NMR techniques. Sample conditions were optimized as described in SI Materials and Methods to obtain high-quality spectra of 15 N∕ 13 C-labeled recombinant domain 5 isolated from the medium of Pichia pastoris yeast (Fig. S2A) . Furthermore, the structures were determined at pH 6.5, which is the optimal pH for ligand binding by the CI-MPR, and in the absence of divalent cations as carbohydrate binding by the CI-MPR is not influenced by the presence of cations. Similar to the crystal structures reported for 7 out of the 15 MRH domains of the CI-MPR and the CD-MPR, domain 5 folds into a flattened 9-stranded β-barrel comprised of two antiparallel β-sheets (β1-β4, and β5-β9 in which β9 interjects between β7 and β8) oriented orthogonally over one another (Fig. 1D) . The overall fold of domain 5 is most similar to domain 3 in that its N-terminus contains several short β-strands rather than a single α-helix as is observed in the CD-MPR (Fig. S3A ). These results demonstrate that the lack of a disulfide bridge in domain 5 does not perturb the overall structure.
Ligand Binding Does Not Alter the Conformation of Domain 5. Comparison of 1 H-15 N heteronuclear single-quantum coherence (HSQC) spectra collected in the absence and presence of ligand (methyl Man-P-GlcNAc or Man-6-P) shows little variation in peak position among residues outside the ligand binding site (Fig. 2 A and B) . These data demonstrate that, unlike CD-MPR that undergoes a dramatic reorientation of a loop upon ligand binding (25, 26) , domain 5 maintains essentially the same structure in the presence and absence of ligand (Fig. S3B) .
However, the dynamic nature of domain 5 becomes apparent when the rmsd are calculated (Fig. S4A) between corresponding Cα atoms for each member of the structure ensemble (Fig. S4B) . Residues located in β-strands exhibit the lowest rmsd values, whereas the loops connecting these strands show the highest positional variation; although higher rmsd values may simply reflect a lack of NOE constraints, reduced 15 N heteronuclear NOE values for many loop residues confirm their flexible nature (Fig. S4A) . A comparison of the conformers also reveals that the side chains of residues in the binding pocket become dramatically less mobile in the presence of ligand (Fig. S4C) . In addition, comparison of the 3D NOESY spectra collected in the presence and absence of ligand shows more interresidue NOE's exist in the bound state than unbound (Table S1 ). Heteronuclear NOE experiments show very similar regions of flexibility between the ligand-bound and the unbound conformations, with the exception of residues in loop C and residues located between β-strands 7 and 8, which become more ordered upon binding methyl Man-P-GlcNAc (Fig. S4A) . Together, these data demonstrate that domain 5 is more dynamic in the ligand-free state.
Binding Affinity Determination. To probe the interaction of domain 5 with ligand, increasing amounts of the monosaccharides Man-6-P (Fig. 1C) or GlcNAc, or the disaccharide methyl Man-P-GlcNAc phosphodiester (Fig. S5D) , were added to 15 N-labeled domain 5 and changes in chemical shifts of amide groups of either backbone or side chains were monitored. No chemical shift changes were observed accompanying the addition of GlcNAc (Fig. S4D) , indicating that domain 5 lacks significant binding affinity to this monosaccharide. In contrast, an overlay of spectra acquired at increasing concentrations of Man-6-P ( Fig. 2A) or methyl Man-P-GlcNAc (Fig. 2B) showed progressive chemical shift changes for residues either within or adjacent to the proposed carbohydrate binding site. The weighted changes in 1 H and 15 N chemical shift were used to calculate binding affinities for Man-6-P (K d ¼ 20 mM) and methyl Man-P-GlcNAc (K d ¼ 1 mM) (Fig. 2C) . These values are consistent with our previous inhibition studies using surface plasmon resonance analyses (23) and demonstrate that the presence of the GlcNAc moiety in the context of the disaccharide Man-P-GlcNAc provides an ∼20-fold enhancement of binding affinity to domain 5 compared to the monosaccharide Man-6-P.
Man-P-GlcNAc Binding Pocket. Measurements of weighted differences in 1 H and 15 N chemical shifts with increasing amounts of ligand were used to map the location of the Man-6-P (Fig. 3 Top) and Man-P-GlcNAc (Fig. 3 Bottom) binding site to the surface of domain 5. The greatest chemical shift perturbations of both ligands map to an area corresponding to the known binding site of CD-MPR and domain 3 of the CI-MPR, with methyl Man-P-GlcNAc covering a more extensive area (Fig. 3) . In the presence of Man-6-P, the largest chemical shift variations involve a small set of residues located in the area around three (i.e., Q644, E709, and Y714) out of the four (R687) residues known to be essential for lysosomal enzyme binding (23) . In contrast to that observed in the presence of Man-6-P (Fig. 3 Top), residues in loop C experience greater chemical shift differences in the presence of the larger ligand (Fig. 3 Bottom) . Because the four MRH domains (CD-MPR, domains 3, 5, and 9 of CI-MPR) utilize the same four amino acids (Gln, Arg, Glu, and Tyr) for mannose recognition, the remaining elements that convey specificity for phosphomonoester versus phosphodiester must lie outside these residues.
Molecular docking studies, detailed analyses of NOE patterns in the presence and absence of ligand, and mutagenesis studies were undertaken to further define the CI-MPR's Man-P-GlcNAcspecific binding pocket. Comparison of the binding site of domain 5 to domain 3 and CD-MPR shows domain 5 to be an amalgam of both pockets (Fig. 4) . The position of loop D is more similar to CD-MPR, whereas the position of loop C relative to the ligand more closely resembles that of domain 3. However, a notable difference is the presence of a conserved W653 in domain 5 (Fig. 4C) , which is absent in the analogous position in CD-MPR (Thr) (Fig. 4A) , domain 3 (Lys) (Fig. 4B) , or domain 9 (Lys) (Fig. 1B) . The indole ring of W653 is in position to interact with the guanidinium group of R687 [one of the four essential residues for ligand binding (23)] (Fig. 4C) . This interaction is predicted to stabilize the pocket in the absence of the disulfide bridge that functions to connect loop C to loop D in the binding pocket of CD-MPR (Fig. 4A) and domain 3 (Fig. 4B) . Using 2D total correlation spectroscopy (TOCSY) data collected on the unlabeled ligand (Fig. S5 A and B) in conjunction with NOEs found only in the ligand-bound structure (Fig. S5C) , it was possible to deduce the chemical shifts of other atoms of the ligand (Fig. S5C  and D) . The protons on the methyl at carbon 1 and carbon 5 of the mannose ring show clear NOEs to the side chain of W653 (Fig. S5E) . W653 positions the mannose ring so that its 2-hydroxyl is oriented toward the side chains of R687 and Q644, which is consistent for the role of these residues as observed in the crystal structures of CD-MPR (17) and domain 3 (18) as well as previously published mutagenesis studies (23) .
Analysis of NOE data also revealed numerous interactions of the methyl group of N-acetylglucosamine with the aromatic ring of Y679 (Fig. S5 F and G) . To evaluate the role of Y679 in ligand recognition by domain 5 of the CI-MPR, surface plasmon resonance studies were performed on wild-type and mutant domain 5. The Y679F mutant exhibits a similar affinity (within ∼2-fold) to GAA monoester and GAA diester as the wild-type domain 5. In contrast, substitution of Y679 with a nonaromatic residue, leucine, greatly diminishes the protein's ability to bind both the GAA monoester (no detectable binding) and GAA diester (10-fold decrease) (Table S2 ). This preference for an aromatic residue at position 679 supports the conclusion that the ligand does indeed interact with Y679. Structural and mutagenesis studies of other lectins that specifically recognize N-acetyl sugars demonstrate a similar mechanism, with the methyl group of the acetamido group in van der Waals contact with a tyrosine [i.e., chicken hepatic lectin (27) ] and/or tryptophan residue [i.e., influenza virus hemagglutinin (28); wheat germ agglutinin (29); tachylectin-2 (30)]. Y679 of domain 5 is conserved in all species sequenced to date and is positionally conserved with the disulfide bond (C385-C419) of domain 3 and Y102 of CD-MPR (Fig. 4) . Although CD-MPR also utilizes a Tyr at this position, the CD-MPR does not interact with phosphodiesters (13) due to the architecture of its binding pocket: The CD-MPR pocket engulfs the terminal phosphate and mannose residue, with no room to accommodate a GlcNAc residue (Fig. 4A) . In contrast, domain 5's pocket is open with a noticeably extended groove on the surface of the molecule that extends out from the position of the 2-and 3-OH of the mannose ring (Fig. 4C) . The binding pocket of domain 3 is intermediate between these two (Fig. 4B) . Structural studies of domain 9, which is specific for phosphomonoesters (16) , are required to determine whether the carbohydrate binding pocket of domain 9 demonstrates features unique to its mechanism of carbohydrate recognition.
Concluding Remarks.
The MPRs play an essential role in lysosome biogenesis. The importance of providing lysosomes with an entire repertoire of degradative enzymes for normal cellular processes is illustrated by the existence of over 35 different monogenic human lysosomal storage diseases that are caused by a deficiency of a catabolic enzyme (31) that together are estimated to affect 1 in 5,000 live births (32) . The ability of the CI-MPR to recognize the product of GlcNAc-phosphotransferase ensures that deficiencies in the uncovering enzyme will not be lethal (11) and allows those acid hydrolases that may be poor substrates for the uncovering enzyme to be delivered in sufficient quantities to the lysosome to prevent the pathologies associated with lysosomal storage diseases. The CI-MPR, via its fifth MRH domain, is the only lectin known to recognize Man-P-GlcNAc, and in the current report we show the molecular basis for this interaction. Our previous studies using a phosphorylated glycan microarray demonstrate that the CI-MPR contains three carbohydrate binding sites (domains 3, 5, and 9) that differ in their glycan specificity, thereby accounting for the broad range of phosphorylated N-glycan structures recognized by this receptor (13, 16) . Given that the CI-MPR is dimeric (33, 34) , the presence of six carbohydrate binding sites in the dimeric receptor would enhance binding affinity by increasing the likelihood that at least two of the receptor's binding sites are favorably positioned to interact with the varying spatial arrays of a diverse set of phosphorylated N glycans displayed by lysosomal enzymes. An intriguing aspect of these studies relates to the evolution of the phosphomannosyl recognition system: The CI-MPR may have been selected to bind the products of both enzymes that generate the recognition tag, GlcNAc-phosphotransferase (Man-P-GlcNAc) and uncovering enzyme (Man-6-P), as a mechanism to supply a protective, functional redundancy to the organism. However, phosphodiester recognition by the CI-MPR may serve other roles in ligand trafficking that remain to be elucidated.
Materials and Methods
Internalization of Lysosomal Enzymes. Generation and maintenance of stably transfected mouse L cell lines expressing either the wild-type CI-MPR or a double mutant, Dom3 Ala 9 Ala , that inactivates the phosphomonoester-specific binding sites located in domain 3 and domain 9 of the CI-MPR have been described previously (24) . Uptake of iodinated lysosomal enzymes was carried out as described previously (35) and is detailed in SI Materials and Methods.
Generation of Constructs. The wild-type domain 5 construct (residues 584-725) originally described by Reddy et al. (36) was cloned into the pPICZαA vector (Invitrogen) utilizing EcoRI and XbaI of the multiple cloning site. The secreted protein contains five extra amino acids (EAEAF) at the N terminus as a result of this strategy. Generation of three mutant domain 5 constructs lacking both N-glycosylation sites (N591Q/N711Q) plus replacement of Tyr at position 679 with Leu (Y679L) or Phe (Y679F) are described in SI Materials and Methods.
Protein Expression and Purification. The domain 5 proteins (wild-type, N591Q/ N711Q, Y679F, and Y679L) were purified from the medium of transformed P. pastoris yeast as described in SI Materials and Methods. Data Collection and Structure Determination by Heteronuclear NMR Spectroscopy. Complete 1 H, 15 N, and 13 C resonance assignments for domain 5 were obtained in a semiautomated manner using peak lists from 3D HNCO, HNCO-CA, HNCOCACB, HNCA, HNCACB, HNCACO, CCONH, HBHACONH, HCCONH, HCCH-TOCSY, and 13 CðaromaticÞ-edited NOESY-HSQC spectra. Structures of domain 5 were calculated using distance constraints derived from 3D 15 N-edited NOESY-HSQC, and 13 C-edited NOESY-HSQC, 13 CðaromaticÞ-edited NOESY-HSQC (τ mix ¼ 80 ms). Backbone ϕ and ψ dihedral angle constraints were generated from secondary shifts of the 1 H, 13 Cα, 13 Cβ, 13 C 0 , and 15 N nuclei using the program TALOS (37) . Initial structures were generated in an automated manner using the NOEASSIGN module of the torsion angle dynamics program CYANA (38), followed by iterative manual refinement to eliminate constraint violations. The 20 CYANA conformers with the lowest target function were further refined by a molecular dynamics protocol in explicit solvent (39) using XPLOR-NIH (40) . The final ensemble is shown in Fig. S4 B and C, and the structural statistics are listed in Table S1 .
Determination of Binding Affinities by Heteronuclear NMR Spectroscopy. NMR studies in which 15 N-labeled domain 5 was titrated with increasing concentrations of ligand [Man-6-P (Sigma), methyl Man-P-GlcNAc (23) (see Fig. S5D ), or GlcNAc (Sigma)] were carried out as described previously (26) and are detailed in SI Materials and Methods.
Molecular Docking. The docking of methyl Man-P-GlcNAc was done using Autodock4.0 and AutodockVINA as described in SI Materials and Methods. Controls are shown in Fig. S6 .
Surface Plasmon Resonance Analysis. Biosensor studies were carried out as described previously (16) and are detailed in SI Materials and Methods.
